Status:
UNKNOWN
Translation and Implementation of the Dutch VVAS Score in Clinical Practice
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Vertigo
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The aim of this study is to translate and introduce a cross-cultural adaptation of The Visual Vertigo Analogue Scale (VVAS). E. Dannenbaum et al developed the VVAS in order to diagnose visual vertigo ...
Detailed Description
The Visual Vertigo Analogue Scale (VVAS) was developed by E. Dannenbaum et al in 2011 to diagnose visual vertigo. It is a nine-item analogue scale in which the subjects can rate their symptoms' intens...
Eligibility Criteria
Inclusion
- All patient with chronic vertigo (\>3 years) will included
- Interpretation of the VVAS is be possible
- 18-75 year
Exclusion
- Unable to read Dutch
- Single episode of vertigo
- \> 75 year
- Minors
- When no interpretation of the VVAS is possible (e.g. too young, dementia)
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06017466
Start Date
October 1 2023
End Date
March 1 2024
Last Update
August 30 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.